IPHA Innate Pharma S.A.

NASDAQ
$1.59

Innate Pharma S.A. (IPHA) Institutional Ownership

What the institutions did with IPHA last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to.

No institutional holdings on record for IPHA.